Clinical Trial Update: 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Zydelig (idelalisib) as maintenance therapy after autologous stem cell transplantation in B-cell non-Hodgkin lymphoma has completed, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Follicular Lymphoma
• Indolent Lymphoma
• Lymphoplasmacytic Lymphoma
• Marginal Zone Lymphoma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Zydelig (idelalisib)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Non Hodgkin Lymphoma, Follicular Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19